SALIX PHARMACEUTICALS INC's ticker is and the CUSIP is 795435AE6. A total of 48 filers reported holding SALIX PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $26,589,000 | +190.7% | 10,000,000 | +100.0% | 0.03% | +188.9% |
| Q4 2014 | $9,148,000 | -62.3% | 5,000,000 | -50.0% | 0.01% | -62.5% |
| Q3 2014 | $24,266,000 | +23.8% | 10,000,000 | 0.0% | 0.02% | +20.0% |
| Q2 2014 | $19,604,000 | +17.1% | 10,000,000 | 0.0% | 0.02% | +11.1% |
| Q1 2014 | $16,743,000 | +8.3% | 10,000,000 | -4.8% | 0.02% | 0.0% |
| Q4 2013 | $15,455,000 | +32.9% | 10,500,000 | +10.5% | 0.02% | +28.6% |
| Q3 2013 | $11,631,000 | +2.2% | 9,500,000 | 0.0% | 0.01% | -6.7% |
| Q2 2013 | $11,377,000 | – | 9,500,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GRACE BROTHERS MANAGEMENT LLC | 2,500,000 | $4,916,000 | 4.33% |
| SYMPHONY ASSET MANAGEMENT LLC | 19,840,000 | $38,948,000 | 4.05% |
| SILVERBACK ASSET MANAGEMENT LLC | 19,709,000 | $38,695,000 | 4.00% |
| MACKAY SHIELDS LLC | 31,471,000 | $61,916,000 | 3.41% |
| Sage Capital Management, LLC | 1,500,000 | $2,942,000 | 2.98% |
| ALTEGRIS ADVISORS, L.L.C. | 250,000 | $491,000 | 2.56% |
| Wellesley Asset Management | 16,220 | $31,923,000 | 2.01% |
| GUARDIAN LIFE INSURANCE CO OF AMERICA | 8,600,000 | $16,883,000 | 1.62% |
| CAMDEN ASSET MANAGEMENT L P /CA | 13,862,000 | $27,213,000 | 1.58% |
| Calamos Wealth Management LLC | 2,061,000 | $4,045,000 | 1.15% |